The National Biosafety Authority (NBA) has invited public input on a proposal to release genetically modified maize, commonly known as Bt maize, into the Kenyan market.
The application was submitted jointly by the Kenya Agricultural and Livestock Research Organisation (KALRO) and the African Agricultural Technology Foundation (AATF).
The NBA is currently reviewing the proposal to ensure the maize’s safety for human and animal consumption, working alongside government agencies and biosafety experts.
Bt maize was developed using modern biotechnology to resist pests such as maize stem borers and fall armyworms, promising reduced crop damage, higher yields, and a decreased reliance on harmful insecticides.
If approved, the maize will undergo further testing under the Seeds and Plant Varieties Act, which requires new crops to pass National Performance Trials (NPTs) in various ecological zones. Even after market release, the NBA plans to monitor compliance with biosafety laws.
In a public notice, the NBA emphasized the importance of public participation in the decision-making process. It encouraged individuals to submit comments either through postal mail or via email at [email protected].
This initiative follows a recent High Court ruling by Justice Lawrence Mugambi that cleared the way for GMO crop rollout in Kenya. The introduction of GMO products has sparked significant debate, with critics raising concerns about potential health risks and environmental impact.
However, the government, led by President William Ruto, has strongly supported GMOs, framing them as a solution to the country’s food insecurity.
Ruto has dismissed fears surrounding GMOs, pointing out that countries like South Africa and the USA have embraced the technology without reported adverse effects.
If approved, the release of Bt maize could significantly impact Kenya’s agricultural sector, boosting productivity while continuing to fuel discussions about the long-term implications of GMO crops.
